Shots: Audentes and NCH enter into a license agreement to develop AT702 designed to induce exon 2 skipping in DMD patients with exon 2 duplications and mutations in exons 1-5 […]readmore
Tags : Nationwide Children’s Hospital
Shots: The exclusive WW collaboration agreement is to evaluate Mustang Bio’ s MB-101 (IL13Rα2-specific CAR) in combination with C134 for the treatment of glioblastoma multiforme The focus of the agreement […]readmore